[Recombinant factor VIII].
Tusell
J M
JM
Unitat d'Hemofilia, Hospital Vall d'Hebrón, Barcelona.
D000818:Animals; D002478:Cells, Cultured; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D006224:Cricetinae; D003412:Cricetulus / Q000276:immunology; D005169:Factor VIII / Q000037:antagonists & inhibitors / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification / Q000627:therapeutic use*; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans; D007518:Isoantibodies / Q000276:immunology; D008647:Mesocricetus / Q000276:immunology; D051379:Mice; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000276:immunology / Q000302:isolation & purification / Q000627:therapeutic use*; D012189:Retrospective Studies
D007518:Isoantibodies; D011994:Recombinant Proteins; D005169:Factor VIII
Factor VIII recombinante.